Losses of 3p13-p24, 5q12-q23, 8p22-p23, 9p21-p24, 10p13-pter, 18q22-q2
3, and 21q11.2-q21 (40-60% of tumors), loss of the inactive X and loss
(or rearrangement) of Y in 70% of tumors from female and male patient
s respectively; and gains of 2 to 5 extra copies of 3q21-qter, 5p14-pt
er, 7p13-p22, 8q13-q24.3, and 11q13-q23, (30-40% of tumors) are the mo
st common chromosome abnormalities in head and neck squamous cell carc
inomas (SCCs). SCCs are monoclonal and cell lines derived from separat
e surgeries in the same patient contain closely related subclones. Ana
lysis of subclones within tumors provides clues to the sequence of kar
yotypic changes. Chromosome hotspots such as loss of distal 18q and ga
ins affecting 11q13-11q21 are likely to contain genes important in the
development and progression of sec.